Molecular pathology for classification of tumors and for efficacy prediction of targeted therapies is a swiftly escalating discipline.During the INSEMA research – a prospectively randomized study comparing SLNE vs. no SLNE in clients with early invasive breast cancer (??five?cm, cN0) and breast-conserving therapy – data onThis investigation or